MOLECULAR PARTNERS ADS/1 (6ML0) — Financial Flexibility Index
MOLECULAR PARTNERS ADS/1 (6ML0) has a Financial Flexibility Index of -0.63x as of June 2026. Free cash flow of €-10.79 Million (operating CF €-10.79 Million minus capex €0.00) represents -1% of total liabilities (€17.15 Million). Check 6ML0 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MOLECULAR PARTNERS ADS/1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for MOLECULAR PARTNERS ADS/1 across 5 annual periods. For the full cash flow conversion analysis, see 6ML0 cash generation efficiency.
Annual Financial Flexibility Index for MOLECULAR PARTNERS ADS/1 (2021–2025)
Year-by-year free cash flow to debt coverage for MOLECULAR PARTNERS ADS/1. Explore MOLECULAR PARTNERS ADS/1 (6ML0) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.32x | €-50.54 Million | €-51.26 Million | €21.77 Million | ▲ +33.0% |
| 2024 | -3.46x | €-58.52 Million | €-59.25 Million | €16.89 Million | ▼ -30.5% |
| 2023 | -2.65x | €-58.20 Million | €-59.01 Million | €21.92 Million | ▼ -159.9% |
| 2022 | 4.43x | €119.98 Million | €118.57 Million | €27.09 Million | ▲ +423.0% |
| 2021 | -1.37x | €-89.65 Million | €-90.95 Million | €65.38 Million | — |